These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization. Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131 [TBL] [Abstract][Full Text] [Related]
10. Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE). Keane G; Lam M; Braat A; Bruijnen R; Kaufmann N; de Jong H; Smits M Cardiovasc Intervent Radiol; 2024 Sep; 47(9):1224-1236. PubMed ID: 38914769 [TBL] [Abstract][Full Text] [Related]
12. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598 [TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Saxena A; Bester L; Chua TC; Chu FC; Morris DL Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691 [TBL] [Abstract][Full Text] [Related]
14. [Locoregional and local ablative treatment options for liver tumors]. Hinrichs JB; Wacker FK Internist (Berl); 2020 Feb; 61(2):158-163. PubMed ID: 31919532 [TBL] [Abstract][Full Text] [Related]
15. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. Edeline J; Lamarca A; McNamara MG; Jacobs T; Hubner RA; Palmer D; Groot Koerkamp B; Johnson P; Guiu B; Valle JW Cancer Treat Rev; 2021 Sep; 99():102258. PubMed ID: 34252720 [TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study. Mosconi C; Gramenzi A; Ascanio S; Cappelli A; Renzulli M; Pettinato C; Brandi G; Monari F; Cucchetti A; Trevisani F; Golfieri R Br J Cancer; 2016 Jul; 115(3):297-302. PubMed ID: 27336601 [TBL] [Abstract][Full Text] [Related]
17. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Wo JY; Dawson LA; Zhu AX; Hong TS Surg Oncol Clin N Am; 2014 Apr; 23(2):353-68. PubMed ID: 24560114 [TBL] [Abstract][Full Text] [Related]
18. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. Fabritius MP; Ben Khaled N; Kunz WG; Ricke J; Seidensticker M J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884275 [TBL] [Abstract][Full Text] [Related]
19. Current management of cholangiocarcinoma. Singh MK; Facciuto ME Mt Sinai J Med; 2012; 79(2):232-45. PubMed ID: 22499494 [TBL] [Abstract][Full Text] [Related]
20. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma. Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]